Sun Pharmaceutical Industries (prev. Ranbaxy Toansa) 483, Jan 2014

Sun Pharmaceutical Industries (prev. Ranbaxy Toansa) 483, Jan 2014

Peter Baker FDA, Dipesh Shah FDA$119.00

FDA investigators audited the Sun Pharmaceutical Industries (prev. Ranbaxy Toansa) facility in Punjab, India and issued inspectional observations (via FDA 483) on 11 Jan 2014.

Buy This DocumentBuy 1-Year 483 Access

Product details

  • Inspection end: 11 Jan 2014
  • Location: Punjab, India